MMP9 and Duchenne muscular dystrophy: Regarding DMD patients, other circulating proteins are being investigated as possible biomarkers, namely matrix metalloproteinase-9 and the tissue inhibitors of metalloproteinase-1, both found increased in DMD patient sera [4].